Maintenance Treatment for Abstinent Smokers

Completed · Phase 3 · Has a placebo group

Conditions studied: Tobacco Use Disorder

In brief

The purpose of this study is to determine the efficacy and cost-effectiveness of long-term pharmacotherapy (using Zyban and/or nicotine replacement) for reducing the relapse rate associated with stopping smoking.

Key facts

Study ID

NCT00063323

Run by

National Institute on Drug Abuse (NIDA)

People needed

589

Starts

2000-08-01

Expected to finish

2006-07-01

Last updated by the study team

2017-01-12

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients who smoke at least 10 cigarettes daily and have attempted to quit smoking at least once

You may not qualify if…

• Seizure History
• Unstable Blood Pressure
• Current major depression
• Current alcohol/drug abuse or dependency
• Lifetime psychotic illness
• Current use of psychotropic drugs
• Unstable medical condition

Where it is running

• New York State Psychiatric Institute — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.